Health
Daiichi Sankyo says it has begun producing AstraZeneca’s COVID-19 vaccine in Japan – TheChronicleHerald.ca
TOKYO (Reuters) – Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc’s COVID-19 vaccine in Japan. The drugmaker said in a release it…

TOKYO (Reuters) – Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc’s COVID-19 vaccine in Japan.
The drugmaker said in a release it will prepare the vaccine in Japan, including vial filling and packaging, using the bulk solution provided by AstraZeneca.
The Japanese government has already arranged to buy 120 million doses of AstraZeneca’s vaccine, enough for 60 million people. Most of the doses will be made in Japan by Daiichi Sankyo, JCR Pharma and other local partners.
…
-
Noosa News22 hours ago
Ensure voices are heard – Proctor
-
Business19 hours ago
Up 34% this year, can Challenger shares keep rising according to Macquarie?
-
Noosa News23 hours ago
City of Moreton Bay claims homeless people consented to having camps thrown away
-
General23 hours ago
Reserve Bank board still looking for yesterday’s news